The European Society of Human Reproduction and Embryology (ESHRE) has launched the Female Reproductive Genetics Initiative (FeRGI), a project aimed at translating genetic research in infertility into clinical practice. Developed within the Special Interest Group (SIG) Reproductive Genetics, FeRGI focuses on providing resources and training to clinicians and biologists to improve the diagnosis and treatment of female infertility. Recent advancements over the…
At the ESHRE Annual Meeting in Amsterdam, data presented revealed that women in Europe are undergoing more cycles of in vitro fertilisation (IVF) and intrauterine insemination (IUI). The data from the ESHRE European IVF Monitoring (EIM) Consortium indicates a steady rise in the use of Assisted Reproductive Technology (ART). In 2021, a total of 1,103,633 ART treatment cycles were reported by 1,382…
Oxolife, a biotech company specializing in female fertility, has announced promising results from a Phase 2 clinical trial of its non-hormonal fertility pill, OXO-001, at the European Society of Human Reproduction and Embryology (ESHRE) 40th Annual Meeting in Amsterdam. The data indicates that OXO-001 significantly improves embryo implantation, pregnancy, and live birth rates in women undergoing in-vitro fertilization (IVF) and intracytoplasmic sperm…
Mira, a hormonal health company providing at-home reproductive health solutions, launches an online Hormone Health Clinic for Fertility aimed to help people – struggling to conceive. The clinic provides personalized support from fertility professionals throughout the conception journey, focusing on addressing hormonal imbalances, streamline nutrition and gut health, setting up effective exercise routines and improving mental health. 1 in 5 people in the US are affected by…
Progyny, a provider of fertility, family building, and women’s health benefits, has announced its strategic acquisition of Apryl, a Berlin-based fertility benefits platform established in 2019. This move bolsters Progyny’s global offerings, providing enhanced guided, concierge support to employees worldwide as they navigate the complexities of fertility and family building care. Progyny’s comprehensive global benefits solution already supports multinational employers and their…
In recognition of Men’s Health Month, Posterity Health has launched its Hormone Management Program across the United States. This program aims to address the issue of low testosterone (Low-T) among American males using best practice clinical protocols to ensure effective and personalized treatment. Low testosterone is a condition affecting over 3 million men in the U.S., with symptoms such as fatigue, poor…
Wisp, a company working in sexual and reproductive health, has taken a step forward by launching a new fertility vertical aimed at supporting women through every stage of their reproductive health journey. Through this strategic move Wisp wants to make healthcare more affordable and accessible for women, especially those facing challenges in conceiving. Fertility is a crucial aspect of women’s reproductive health,…
In a significant leadership shift, Gina Bartasi, the founder and executive chairman of Kindbody, has returned to her role as CEO to steer the company through its next phase of growth. Kindbody is known as a leading national fertility clinic network in the U.S. and global family-building benefits provider. Kindbody was founded by Bartasi in late 2018, and has grown into the…
